is tirzepatide better than zepbound vs zepbound vs retatrutide Retatrutide vs

Live birth rates were significantly lower in women with class I and class IIIII obesity

Not approved for diagnostic, therapeutic, or medical applications

Smaller portions and gentle nutrition support

M&F is not endorsing the websites or products listed in this article

The SURMOUNT clinical trial programme, which included over 2,500 participants, demonstrated that tirzepatide at the 15 mg dose produced an average weight reduction of approximately 2022% of body weight compared to placebo over 72 weeks

Energy balance: encourage smaller, #nutrientdense #meals rather than calorie restriction, and recommend #wholegrains for #satiety and sustained energy and #healthyfats to support fat-soluble #vitamin #absorption and reduce cholestasis